| Consumer Staples Distribution & Retail Industry | Consumer Staples Sector | Mr. David Utama CEO | IDX Exchange | ID1000070303 ISIN |
| Indonesia Country | 9,643 Employees | 23 May 2022 Last Dividend | - Last Split | 4 Jul 2001 IPO Date |
PT Kimia Farma Tbk is a prominent Indonesian company specializing in the pharmaceutical industry, with a foundation date going back to 1817. It has established itself as an integral part of Indonesia's healthcare system, engaging in the manufacturing and distribution of a wide range of pharmaceutical products, herbal medicines, and more. The company's operations are segmented into Manufacturing, Distribution, Retail, and Other Services. With its headquarters in Jakarta, Indonesia, PT Kimia Farma Tbk not only serves the local market but also exports products internationally, reaching regions such as Asia, Europe, Australia, Africa, and the United States. Through balancing traditional values with innovative approaches, the company continues to be at the forefront of the pharmaceutical industry in Indonesia and beyond.
PT Kimia Farma Tbk offers a broad range of pharmaceutical products including generic, ethical (prescription), license, and narcotic medicines. This diversity caters to various healthcare needs, ensuring wide accessibility to essential medication across different segments of the population.
The company provides an array of over the counter (OTC) medicines, aimed at addressing common health concerns. These are readily available to consumers, helping to manage and treat minor ailments efficiently without the need for a prescription.
Focusing on the pharmaceutical industry's supply chain, PT Kimia Farma Tbk manufactures and markets pharmaceutical raw materials and active pharmaceutical ingredients. This not only supports their product development but also caters to the broader market, sustaining the production of diverse pharmaceutical goods.
The range of health products includes health foods, effervescent tablets, and nutritional supplements. These products aim to support overall wellbeing and healthy lifestyles, complementing the company's pharmaceutical offerings.
Specializing in the production of quinine salt and its derivatives, PT Kimia Farma Tbk leverages Indonesia's rich biodiversity for the extraction and processing of these valuable products, primarily used for treating malaria and other medical uses.
The company extends its expertise into producing castor oil and edible oil, showcasing its versatility in the pharmaceutical and food industries. These oils are significant for various industrial and pharmaceutical applications.
PT Kimia Farma Tbk also ventures into the manufacturing of medical devices and rapid test diagnostic tools. This expansion emphasizes the company's commitment to supporting not just therapeutic but also diagnostic aspects of healthcare.
Along with healthcare products, the company offers a range of cosmetic products. This diversification aligns with the broader health and wellness trends, catering to consumer demands for comprehensive personal care solutions.